These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27102362)

  • 21. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) and homologous recombination regulatory genes in invasive ductal breast carcinomas.
    da Silveira GG; Oliveira-Costa JP; Soave DF; Zanetti JS; Soares FA; Ribeiro-Silva A
    Histol Histopathol; 2012 Oct; 27(10):1353-9. PubMed ID: 22936454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
    Szkandera J; Pichler M; Absenger G; Stotz M; Weissmueller M; Samonigg H; Asslaber M; Lax S; Leitner G; Winder T; Renner W; Gerger A
    Clin Cancer Res; 2014 Mar; 20(6):1687-97. PubMed ID: 24470513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence.
    Belt EJ; Stockmann HB; Delis-van Diemen PM; Bril H; Tijssen M; van Essen HF; Heymans MW; Beliën JA; Carvalho B; Cillessen SA; Meijer GA
    J Surg Oncol; 2014 Mar; 109(3):255-65. PubMed ID: 24249458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
    André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
    J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p66 Shc tumor levels show a strong prognostic correlation with disease outcome in stage IIA colon cancer.
    Grossman SR; Lyle S; Resnick MB; Sabo E; Lis RT; Rosinha E; Liu Q; Hsieh CC; Bhat G; Frackelton AR; Hafer LJ
    Clin Cancer Res; 2007 Oct; 13(19):5798-804. PubMed ID: 17908971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancer.
    Öhrling K; Karlberg M; Edler D; Hallström M; Ragnhammar P
    Clin Colorectal Cancer; 2013 Jun; 12(2):128-35. PubMed ID: 23276521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
    Hsu YC; Luo CW; Huang WL; Wu CC; Chou CL; Chen CI; Chang SJ; Chai CY; Wang HC; Chen TY; Li CF; Pan MR
    Radiother Oncol; 2020 Aug; 149():249-258. PubMed ID: 32592893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
    Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
    Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
    Gray RG; Quirke P; Handley K; Lopatin M; Magill L; Baehner FL; Beaumont C; Clark-Langone KM; Yoshizawa CN; Lee M; Watson D; Shak S; Kerr DJ
    J Clin Oncol; 2011 Dec; 29(35):4611-9. PubMed ID: 22067390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of BMI1 and FSCN1 expression in colorectal cancer.
    Alajez NM
    Saudi J Gastroenterol; 2016; 22(4):288-93. PubMed ID: 27488323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BMI1 gene expression in myeloid leukemias and its impact on prognosis.
    Saudy NS; Fawzy IM; Azmy E; Goda EF; Eneen A; Abdul Salam EM
    Blood Cells Mol Dis; 2014 Dec; 53(4):194-8. PubMed ID: 25084695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer.
    Swets M; Zaalberg A; Boot A; van Wezel T; Frouws MA; Bastiaannet E; Gelderblom H; van de Velde CJ; Kuppen PJ
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the expression of cancer stem cell marker BMI1 and glioma prognosis.
    Tsai YT; Wu CC; Ko CY; Hsu TI; Chang WC; Lo WL; Chuang JY
    Biochem Biophys Res Commun; 2021 Apr; 550():113-119. PubMed ID: 33691197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High tumor mast cell density is associated with longer survival of colon cancer patients.
    Mehdawi L; Osman J; Topi G; Sjölander A
    Acta Oncol; 2016 Dec; 55(12):1434-1442. PubMed ID: 27355473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the Polycomb-Group protein BMI1 and correlation with p16 in astrocytomas an immunohistochemical study on 80 cases.
    Tirabosco R; De Maglio G; Skrap M; Falconieri G; Pizzolitto S
    Pathol Res Pract; 2008; 204(9):625-31. PubMed ID: 18450386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.